Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
3,963,565
-
Shares change
-
-194,777
-
Total reported value, excl. options
-
$34,247,851
-
Value change
-
-$2,001,192
-
Number of buys
-
20
-
Number of sells
-
-27
-
Price
-
$8.64
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q1 2022
63 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2022.
XBiotech Inc. - Common Shares, no par value (XBIT) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,963,565 shares
of 33,289,095 outstanding shares and own 11.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,029,110 shares), VANGUARD GROUP INC (928,677 shares), STATE STREET CORP (323,970 shares), GEODE CAPITAL MANAGEMENT, LLC (296,670 shares), CREDIT SUISSE AG/ (155,795 shares), DIMENSIONAL FUND ADVISORS LP (153,918 shares), NORTHERN TRUST CORP (153,233 shares), Nuveen Asset Management, LLC (88,400 shares), Allspring Global Investments Holdings, LLC (88,312 shares), and Bank of New York Mellon Corp (78,874 shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.